Get started
Qualigen Therapeutics, Inc.Qualigen Therapeutics, Inc.Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

QLGN chart

Key stats

Market capitalization
‪1.88 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.5281USD
Net income
‪−12.81 M‬USD
Revenue
—
Shares float
‪5.60 M‬
Beta (1Y)
−0.15

About Qualigen Therapeutics, Inc.

Sector
Health Technology
CEO
Michael S. Poirier
Headquarters
Carlsbad
Website
qualigeninc.com
Employees (FY)
4
Founded
2004
ISIN
US74754R2022
FIGI
BBG008D03RS4
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of QLGN is 0.3117 USD — it has increased by 4.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Qualigen Therapeutics, Inc. stocks are traded under the ticker QLGN.
Qualigen Therapeutics, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
QLGN stock is 13.79% volatile and has beta coefficient of −0.15. Check out the list of the most volatile stocks — is Qualigen Therapeutics, Inc. there?
QLGN earnings for the last quarter are −0.69 USD whereas the estimation was −0.52 USD which accounts for −32.69% surprise. Estimated earnings for the next quarter are −0.92 USD. See more details about Qualigen Therapeutics, Inc. earnings.
Qualigen Therapeutics, Inc. revenue for the last quarter amounts to ‪1.63 M‬ USD despite the estimated figure of ‪1.60 M‬ USD. In the next quarter revenue is expected to reach ‪500.00 K‬ USD.
Yes, you can track Qualigen Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
QLGN stock has fallen by 19.66% compared to the previous week, the month change is a 11.82% fall, over the last year Qualigen Therapeutics, Inc. has showed a 68.57% decrease.
QLGN net income for the last quarter is ‪−2.47 M‬ USD, while the quarter before that showed ‪−3.04 M‬ USD of net income which accounts for 18.75% change. Track more Qualigen Therapeutics, Inc. financial stats to get the full picture.
Today Qualigen Therapeutics, Inc. has the market capitalization of ‪1.97 M‬, it has decreased by 4.62% over the last week.
No, QLGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QLGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Qualigen Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
QLGN reached its all-time high on Jun 24, 2015 with the price of 13749.7500 USD, and its all-time low was 0.2946 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 4.00 employees. See our rating of the largest employees — is Qualigen Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Qualigen Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Qualigen Therapeutics, Inc. stock shows the sell signal. See more of Qualigen Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.